Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2024

Description

Generative artificial intelligence (AI) in the pharmaceutical industry utilizes advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and streamline drug discovery. It employs techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions.

Generative AI in pharmaceuticals primarily focuses on two types of molecules such as small molecules and large molecules. Small-molecule drugs are low-molecular-weight compounds that can easily penetrate cells and influence biological processes. Technologies involved include deep learning, natural language processing, querying methods, and context-aware processing, which are applied in areas such as clinical trial research, drug discovery, and research and development.

The generative artificial intelligence (AI) in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in pharmaceutical market statistics, including generative artificial intelligence (AI) in pharmaceutical industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in pharmaceutical market share, detailed generative artificial intelligence (AI) in pharmaceutical market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in pharmaceutical industry. This generative artificial intelligence (AI) in pharmaceutical market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The generative artificial intelligence (AI) in the pharmaceutical market size has grown exponentially in recent years. It will grow from $1.41 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 31%. The growth during the historic period can be attributed to several factors, including advancements in computational power, the rise of big data in healthcare and pharmaceuticals, increased investment in research and development, enhanced data quality and integration, and the expansion of cloud computing.

The generative artificial intelligence (AI) in the pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $5.47 billion in 2028 at a compound annual growth rate (CAGR) of 31.1%. The projected growth during the forecast period can be attributed to a focus on early disease detection, supportive regulatory frameworks and guidelines, improved computational power, rising drug development costs, and increased data availability. Key trends expected in the forecast period include the integration of blockchain and AI, advanced data integration techniques, enhanced disease diagnosis, automated drug repurposing, and real-time optimization of clinical trials.

The growing emphasis on personalized medicine is set to drive the advancement of generative artificial intelligence (AI) within the pharmaceutical industry. Personalized medicine customizes medical treatments based on individual patient characteristics, including genetic, environmental, and lifestyle factors. This increasing focus is supported by advancements in genetic research and technology, which facilitate more precise and effective treatments tailored to individual needs. Generative AI plays a crucial role in this field by enabling the development of customized drug therapies, thereby enhancing treatment efficacy and patient outcomes. For example, the Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 novel personalized therapies for rare diseases in 2023, a significant increase from six approvals in 2022. Consequently, the rise in personalized medicine is fueling the growth of generative AI in the pharmaceutical sector.

Leading companies in the generative AI pharmaceutical market are creating innovative products such as AI healthcare microservices to enhance drug discovery processes. These modular, cloud-based services use AI to improve various healthcare functions, such as drug discovery, medical imaging, and diagnostics. For instance, Nvidia Corporation introduced generative AI microservices in March 2024, featuring optimized NIM AI models and workflows with APIs for cloud-native applications. These microservices offer advanced capabilities in imaging, natural language processing, and speech recognition, as well as digital biology functions. Tools such as Parabricks, MONAI, NeMo, Riva, and Metropolis are available as CUDA-X microservices, improving workflows in drug discovery and genomics.

In June 2023, Eli Lilly and Company, a US-based pharmaceutical and biomedical research firm, entered into a partnership with XtalPi Inc. This collaboration aims to utilize XtalPi's advanced AI-driven drug discovery platform, ID4Inno, to design and develop drug candidates for a specific, undisclosed target. The partnership will leverage XtalPi's technology to explore extensive chemical spaces and identify promising drug candidates through iterative design, synthesis, testing, and analysis, all supported by autonomous robotic systems for enhanced efficiency and precision. XtalPi Inc., based in China, specializes in AI-powered drug research and development.

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2023. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in pharmaceutical market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in pharmaceutical market includes revenues earned by entities through drug design, clinical trial optimization, biomarker discovery, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative artificial intelligence (AI) in pharmaceutical market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative artificial intelligence (AI) in pharmaceutical ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative artificial intelligence (AI) in pharmaceutical market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Small Molecule; Large Molecule
2) By Technology: Deep Learning; Natural Language Processing; Querying Method; Context-Aware Processing; Other Technologies
3) By Application: Clinical Trial Research; Drug Discovery; Research And Development; Other Applications
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20629

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Characteristics

3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size and Growth

5.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

6.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Small Molecule
Large Molecule
6.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Deep Learning
Natural Language Processing
Querying Method
Context-Aware Processing
Other Technologies
6.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinical Trial Research
Drug Discovery
Research And Development
Other Applications

7. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regional And Country Analysis

7.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market

8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generative Artificial Intelligence (AI) In Pharmaceutical Market

9.1. China Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
9.2. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generative Artificial Intelligence (AI) In Pharmaceutical Market

10.1. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market

11.1. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
11.2. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market

12.1. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market

13.1. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market

14.1. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
14.2. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

15.1. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
15.2. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market

16.1. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market

17.1. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generative Artificial Intelligence (AI) In Pharmaceutical Market

18.1. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market

19.1. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market

20.1. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

21.1. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
21.2. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market

22.1. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market

23.1. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
23.2. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market

24.1. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
24.2. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market

25.1. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
25.2. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market

26.1. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
26.2. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market

27.1. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market

28.1. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
28.2. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market

29.1. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
29.2. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Company Profiles

30.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape
30.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holding AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Generative Artificial Intelligence (AI) In Pharmaceutical Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Sanofi S.A.
31.3. Bristol-Myers Squibb Company
31.4. AstraZeneca PLC
31.5. Novartis AG
31.6. GlaxoSmithKline plc
31.7. Fujitsu Limited
31.8. Takeda Pharmaceutical Company Limited
31.9. Eli Lilly and Company
31.10. Amgen Inc.
31.11. Gilead Sciences Inc.
31.12. NVIDIA Corporation
31.13. Conduent Incorporated
31.14. XtalPi Inc.
31.15. Insilico Medicine Inc.

32. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Benchmarking

33. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

35. Generative Artificial Intelligence (AI) In Pharmaceutical Market Future Outlook and Potential Analysis

35.1 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2028 - Countries Offering Most New Opportunities
35.2 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2028 - Segments Offering Most New Opportunities
35.3 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer